+161.8%
MS vs CTSH
+6.0%
+155.8%
-29.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CTSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.9% | +1.2% | -7.1% | -6.2% |
| 7D | -3.4% | +6.4% | -9.8% | -4.7% |
| 30D | -3.9% | +16.3% | -20.2% | -7.4% |
| 3M | -15.9% | +20.0% | -35.9% | -20.1% |
| 6M | -2.5% | +29.9% | -32.4% | -9.7% |
| YTD | +5.1% | -18.4% | +23.5% | +19.7% |
| 1Y | +13.0% | -8.9% | +21.8% | +21.0% |
| All | +161.8% | +6.0% | +155.8% | +151.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CTSH.
Daily Out/Under-Performance
Portfolio return minus CTSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CTSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CTSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling